FDA regulations and prescription digital therapeutics: Evolving with the technologies they regulate
Technological progress in digital therapeutics-and, in particular prescription digital therapeutics (PDTs)-has outpaced the processes that the Food and Drug Administration (FDA) uses to regulate such products. Digital therapeutics have entered the health care ecosystem so rapidly that substantial mi...
Saved in:
Main Authors: | Anthony Watson (Author), Richard Chapman (Author), Gigi Shafai (Author), Yuri A. Maricich (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder
by: Velez FF, et al.
Published: (2021) -
Regulating vaccines at the FDA: development and licensure of Zika vaccines
by: Marion F. Gruber, et al.
Published: (2017) -
Social Media is Addictive and Influences Behavior: Should it Be Regulated as a Digital Therapeutic?
by: Eric Perakslis, et al.
Published: (2023) -
Veterinary Compounding: Regulation, Challenges, and Resources
by: Gigi Davidson
Published: (2017) -
Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation; Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters"
by: Tim K. Mackey
Published: (2016)